Prelude Therapeutics PRLD
NASDAQ PRLD
$3.91 -0.05 (-1.26%)
At close: Sep 30, 2026 · 4:00 PM EDT

Prelude Therapeutics (PRLD) Other Non-Current Assets (2020 - 2026)

Updated

Prelude Therapeutics (PRLD) posted Other Non-Current Assets of $3.41 million for Q2 2026, down 15.8% from $4.04 million a year earlier but up 5.3% from the prior quarter.

Analysis

Prelude Therapeutics (PRLD) Other Non-Current Assets (2020 - 2026) Analysis & Trends

At the end of FY2025, Prelude Therapeutics' Other Non-Current Assets came in at $3.24 million, down 20.0% from FY2024.

  • Annual Other Non-Current Assets shows a five-year compound annual growth rate of 60.8% (FY2020 to FY2025).
  • In prior years, Prelude Therapeutics' Other Non-Current Assets was $4.04 million in FY2024 (unchanged), $4.04 million in FY2023 (-24.8%), $5.38 million in FY2022 (+32.9%) and $4.04 million in FY2021.
  • Quarterly Other Non-Current Assets has run from a low of $3.24 million in Q3 2025 to a high of $12.47 million in Q3 2023 over five years.
  • On a year-over-year basis, Other Non-Current Assets has declined in each of the last four quarters, with an average decline of 17.9% over the last eight quarters.
  • The strongest year-over-year quarter for Other Non-Current Assets in the past five years was Q1 2023, with growth of 203.7%; the weakest was Q3 2024, with a decline of 67.6%.
  • According to Business Quant data, Other Non-Current Assets for the three prior quarters was $3.24 million (Q1 2026), $3.24 million (Q4 2025) and $3.24 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Prelude Therapeutics 312.03 Mn -285.27 Mn - 3.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.41 Mn
Mar 31, 2026 3.24 Mn
Dec 31, 2025 3.24 Mn
Sep 30, 2025 3.24 Mn
Jun 30, 2025 4.04 Mn
Mar 31, 2025 4.04 Mn
Dec 31, 2024 4.04 Mn
Sep 30, 2024 4.04 Mn
Jun 30, 2024 4.04 Mn
Mar 31, 2024 4.04 Mn
Dec 31, 2023 4.04 Mn
Sep 30, 2023 12.47 Mn
Jun 30, 2023 9.36 Mn
Mar 31, 2023 12.28 Mn
Dec 31, 2022 5.38 Mn
Sep 30, 2022 4.93 Mn
Jun 30, 2022 4.04 Mn
Mar 31, 2022 4.04 Mn
Dec 31, 2021 4.04 Mn
Dec 31, 2020 301,000.00
API Access

Prelude Therapeutics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=PRLD&period=max&api_key=YOUR_API_KEY